concept

AUTOPHAGY-LYSOSOME PATHWAY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AUTOPHAGY-LYSOSOME PATHWAY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

46Connections
8Hypotheses
5Analyses
27Outgoing
19Incoming
19Experiments
6Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAUTOPHAGY-LYSOSOME PATHWAY
Key Genes/ProteinsAMPK, C9orf72, NLRP3, SQSTM1, TARDBP, TBK1
Related DiseasesAMYOTROPHIC LATERAL SCLEROSIS, AUTOPHAGY, DEMENTIA, FRONTOTEMPORAL DEMENTIA, MITOPHAGY

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Autophagy-Lysosome Pathway in Neurodegeneration

mechanism · 2348 words

Pathway Diagram

graph TD
    AUTOPHAGY_LYSOSOME_PATHWAY["AUTOPHAGY-LYSOSOME PATHWAY"]
    AUTOPHAGY_LYSOSOME_PATHWAY -->|"degrades"| NLRP3["NLRP3"]
    AUTOPHAGY_LYSOSOME_PATHWAY -->|"degrades"| SCIN["SCIN"]
    AUTOPHAGY_LYSOSOME_PATHWAY -->|"involved_in"| Glucocorticoid_Induced_Muscle_["Glucocorticoid-Induced Muscle Atrophy"]
    AUTOPHAGY_LYSOSOME_PATHWAY -->|"regulates"| alpha_synuclein["alpha-synuclein"]
    Schaftoside["Schaftoside"] -->|"activates"| AUTOPHAGY_LYSOSOME_PATHWAY
    extracellular_matrix_remodelin["extracellular matrix remodeling"] -->|"enhances"| AUTOPHAGY_LYSOSOME_PATHWAY
    CAMK2D["CAMK2D"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
    ASTROCYTE["ASTROCYTE"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
    Obestatin["Obestatin"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
    MTOR["MTOR"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
    mTOR["mTOR"] -->|"regulates"| AUTOPHAGY_LYSOSOME_PATHWAY
    alpha_synuclein -->|"inhibits"| AUTOPHAGY_LYSOSOME_PATHWAY

Outgoing (27)

TargetRelationTypeStr
NLRP3degradesprotein0.90
TDP-43 Aggregationinvolved_inmechanism0.85
SCINdegradesprotein0.85
Glucocorticoid-Induced Muscle Atrophyinvolved_indisease0.80
proteostasis networkmodulatesprocess0.70

Incoming (19)

SourceRelationTypeStr
extracellular matrix remodelingenhancesprocess0.90
35000546are degraded bypaper0.90
TDP-43inhibitsprotein0.90
Schaftosideactivatescompound0.90
lnc-HIBADH-4/miR-326/CTSDregulatespathway0.90

Targeting Hypotheses (8)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Transcriptional Autophagy-Lysosome Coupling 0.777 neurodegeneration Autophagy-lysosome pathway convergence a
Early Proteasome Restoration Therapy 0.712 neurodegeneration Gene expression changes in aging mouse b
Autophagosome Maturation Checkpoint Control 0.709 neurodegeneration Autophagy-lysosome pathway convergence a
VCP-Mediated Autophagy Enhancement 0.595 alzheimers Tau propagation mechanisms and therapeut
TFEB Nuclear Translocation Clears α-Synuclein via Autophagy- 0.580 neurodegeneration Test Preregistration Analysis
HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lys 0.560 neurodegeneration What are the optimal oxygen pressure, du
CHIP-mediated K63-linked ubiquitination promotes autophagoso 0.380 protein-biochemistry Do chaperones selectively recognize path
TFEB-mediated Autophagy Enhancement to Clear Protein Aggrega 0.380 proteomics Quantitative proteomics of the aging syn

Mentioning Analyses (5)

Scientific analyses that reference this entity

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

neurodegeneration | 2026-04-25 | 12 hypotheses Top: 0.640

Why have numerous phase 3 clinical trials failed despite advances in understandi

neurodegeneration | 2026-04-12 | 1 hypotheses Top: 0.566

How can senescent microglia be molecularly distinguished from beneficial activat

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.720

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-04 | 18 hypotheses Top: 0.814

Autophagy-lysosome pathway convergence across neurodegenerative diseases

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.777

Experiments (19)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Meta-analysis of LRP1 C766T polymorphism and Alzheimer's disease susce exploratory Alzheimer's disease 0.950 0.00 human patients proposed N/A
Endothelial CD2AP knockdown effects on memory in male mice validation Alzheimer's disease 0.900 0.00 male mice proposed N/A
Amyloid plaque load analysis in triple-mutant mouse brains exploratory Alzheimer's disease 0.880 0.00 APP/PSEN1/GD3S-/- triple-trans proposed N/A
Reelin treatment rescue via ApoER2 in CD2AP mutant mice validation Alzheimer's disease 0.870 0.00 mice proposed N/A
Network Pharmacology Analysis of Shared AD Targets exploratory Alzheimer's disease 0.850 0.00 Computational network analysis proposed N/A
MRI Phenotyping Method Concordance in Serbian AD Cohort clinical Alzheimer's disease 0.850 0.00 human patients proposed N/A
Endothelin-1 receptor A antagonist rescue in male CD2AP mice validation Alzheimer's disease 0.850 0.00 male mice proposed N/A
Endothelin-1 receptor A antagonist rescue experiment validation Alzheimer's disease 0.850 0.00 mice proposed N/A
Neuroimmune modulation and Aβ clearance mechanisms exploratory Alzheimer's disease 0.820 0.00 Microglia and astrocytes proposed N/A
Competing endogenous RNA (ceRNA) network construction exploratory Alzheimer's disease 0.750 0.00 computational network analysis proposed N/A
Autophagy Enhancement Drug Screening for Neurodegeneration clinical Alzheimer's Disease 0.400 0.50 human proposed $6,550,000
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Macroautophagy Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Validate Mitochondria-Lysosome Contact Site Dysfunction in PD validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic Target Val validation Neurodegeneration 0.400 0.50 human proposed $3,000,000
MLCS Quantification in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
Presymptomatic GRN Carrier Intervention Timing — Biomarker-Guided Ther clinical Neurodegeneration 0.400 0.50 human proposed $5,460,000
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu validation Neurodegeneration 0.400 0.50 human proposed $2,730,000
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment Design clinical Parkinson's Disease 0.400 0.50 human proposed $7,500,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Autophagy and ALS: mechanistic insights and therapeutic implications. [PMID:34057020] Chua JP, De Calbiac H, Kabashi E, Barmad Autophagy 2022 2
Systemic Neurodegeneration and Brain Aging: Multi-Omics Disintegration, Proteost [PMID:40868276] Voicu V, Toader C, Șerban M, Covache-Bus Biomedicines 2025 1
Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammati [PMID:37678798] Pan Q, Gao M, Kim D, Ai W, Yang W, Jiang Cell Mol Gastroenterol Hepatol 2024 1
Acetylation in the regulation of autophagy. [PMID:35435793] Xu Y, Wan W Autophagy 2023 1
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] Zhang T, Xu D, Trefts E, Lv M, Inuzuka H Science 2023 1
Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and inv [PMID:35176466] Zhang L, Liang B, Xu H, Gong Y, Hu W, Ji J Ethnopharmacol 2022 1
New insights regarding SNARE proteins in autophagosome-lysosome fusion. [PMID:32924745] Tian X, Teng J, Chen J Autophagy 2021 1
Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] Wang Y, An H, Liu T, Qin C, Sesaki H, Gu Cell Rep 2019 1
AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] Song X, Zhu S, Chen P, Hou W, Wen Q, Liu Curr Biol 2018 1
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in gl [PMID:28675664] Cid-Díaz T, Santos-Zas I, González-Sánch J Cachexia Sarcopenia Muscle 2017 1
Autophagosomes form at ER-mitochondria contact sites. [PMID:23455425] Hamasaki M, Furuta N, Matsuda A, Nezu A, Nature 2013 1
Gut Microbiota-Derived Tyrosol Alleviates Radiation-Induced Intestinal Injury vi [PMID:41800257] Jin X, Xue H, Shi X, Zhou Y, Zhang J, Ze International journal of biolo 2026 0
PTEN loss drives B7H3 upregulation via the mTORC2/FOXO/c-Myc axis to promote tum [PMID:41920736] Wang Z, Jin N, Li X, Ma X, Feng Y, Yin K Cell reports 2026 0
SNX16 functions as a nutrient-sensitive regulator of autophagosomal components r [PMID:41593027] Que H, Rong Y Autophagy 2026 0
TMEM259/MEMBRALIN is a non-canonical ER-phagy receptor that associates with MAN1 [PMID:41799849] Camilleri JM, Zhang J, Wang T, Ahmad I, Autophagy reports 2026 0
Mammalian lipophagy: process and function. [PMID:41681129] Zhao R, Dai E, Kang R, Liu J, Klionsky D Autophagy 2026 0
TAZ alleviates ischemic stroke injury by activating Foxo1: Usp1-mediated deubiqu [PMID:41921828] ["Xin Y", "Sun Y", "Pan E", "Li M", "Che Free radical biology & medicin 2026 0
Unveiling the Genomic Landscape of Yan Goose (Anser cygnoides): Insights into Po [PMID:41594384] Qi S, Ai Z, Cai Y, Zhang Y, Zhao W et al Animals (Basel) 2026 0
Combining network pharmacology and multi-omics reveals the role of Shengdihuang- [PMID:41655545] Cao X, Shang Y, Qu M, Kang Q, Xu Y et al Phytomedicine 2026 0
Comparative transcriptomics of adherent and suspension chicken fibroblast cell l [PMID:41763754] Contreras EJ, Nagarajan A, Bromberg BH, Food Res Int 2026 0

Debates (6)

Multi-agent debates referencing this entity

What are the optimal oxygen pressure, duration, and frequency parameters for HBO

closed · Rounds: 4 · Score: 0.68 · 2026-04-25

The debate revealed that microglial senescence markers are poorly defined compar

closed · Rounds: 4 · Score: 0.72 · 2026-04-22

Why have numerous phase 3 clinical trials failed despite advances in understandi

closed · Rounds: 5 · Score: 0.67 · 2026-04-12

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.90 · 2026-04-12

Multiple NDDs converge on autophagy-lysosome dysfunction. Are there universal th

closed · Rounds: 4 · Score: 0.90 · 2026-04-06

Tau propagation mechanisms and therapeutic interception points

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

Related Research

Hypotheses and analyses mentioning AUTOPHAGY-LYSOSOME PATHWAY in their description or question text

HBOT (2.0 ATA, 60 min) activates TFEB-mediated autophagy-lysosome pathway to acc

Score: 0.560 · neurodegeneration · 2026-04-25

HBOT increases mTORC1 inhibition, promoting TFEB nuclear translocation and enhancing autophagy flux to clear pathologica

CHIP-mediated K63-linked ubiquitination promotes autophagosomal sequestration of

Score: 0.380 · protein-biochemistry · 2026-04-27

The carboxy terminus of Hsc70-interacting protein (CHIP, encoded by STUB1) functions as a dual-specificity E3 ubiquitin

TFEB-mediated Autophagy Enhancement to Clear Protein Aggregates in Neurodegenera

Score: 0.380 · proteomics · 2026-04-27

This hypothesis proposes that TFEB activation serves as a therapeutic strategy for neurodegenerative diseases by enhanci